What are Desmoid Tumors?

Desmoid tumors, also known as aggressive fibromatosis, are rare soft tissue tumors that arise from connective tissue. They are locally invasive but do not metastasize to other parts of the body.

How big is the Desmoid Tumor Treatment Market?

The global Desmoid Tumor Treatment Market size was estimated at USD 2.5 Billion in 2023 and is expected to reach USD 5.2 Billion in 2033.

What is the Desmoid Tumor Treatment Market growth?

The global Desmoid Tumor Treatment Market is expected to grow at a compound annual growth rate of 7.6%. From 2024 To 2033

Who are the key companies/players in the Desmoid Tumor Treatment Market?

Some of the key players in the Desmoid Tumor Treatment Markets are Horizon Therapeutics Plc, Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Mylan N.V., Assertio Holdings, Inc., Alembic Pharmaceuticals Limited, Apotex Inc., Bayer AG, Sun Pharmaceutical Industries Ltd.

What are the common treatment options for Desmoid Tumors?

Treatment options for Desmoid Tumors may include surgery, chemotherapy, radiation therapy, targeted therapy, and watchful waiting. The choice of treatment depends on factors such as tumor location, size, and aggressiveness, as well as patient preferences.

How prevalent are Desmoid Tumors?

Desmoid Tumors are rare, with an estimated annual incidence of 2-4 cases per million individuals. They can occur at any age but are most commonly diagnosed in adults between the ages of 15 and 60 years.

Are there any emerging treatments or research areas for Desmoid Tumors?

Yes, there are ongoing research efforts focused on developing novel treatment modalities for Desmoid Tumors. These include targeted therapies, immunotherapy, and gene therapy, as well as investigations into the underlying molecular pathways driving tumor growth.

Desmoid Tumor Treatment Market By Diagnosis (Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis) By Treatment (Surgery, Radiation Therapy, Hormone Therapy, Other Treatments) By End User (Hospitals and Clinics, Specialty Centers, Other End-Users) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Feb 2024
Report ID: 77174
Number of Pages: 340
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Horizon Therapeutics Plc
- Amneal Pharmaceuticals LLC
- Hikma Pharmaceuticals PLC
- Zydus Lifesciences
- Mylan N.V.
- Assertio Holdings, Inc.
- Alembic Pharmaceuticals Limited
- Apotex Inc.
- Bayer AG
- Sun Pharmaceutical Industries Ltd